*/

Commonwealth of Kentucky 

Workers’ Compensation Board

 

 

 

OPINION ENTERED:  January 6, 2017

 

 

CLAIM NO. 200598138

 

 

STEVE KAREKEN                                 PETITIONER

 

 

VS.        APPEAL FROM HON. JANE RICE WILLIAMS,

                 ADMINISTRATIVE LAW JUDGE

 

 

MH LOGISTICS;

DR STEPHEN C PAYNE;

DR KYAW HTIN;

HON. JANE RICE WILLIAMS,

ADMINISTRATIVE LAW JUDGE                      RESPONDENTS

 

 

OPINION

AFFIRMING

                       * * * * * *

 

 

BEFORE:  ALVEY, Chairman, STIVERS and RECHTER, Members. 

 

RECHTER, Member.  Steve Kareken (“Kareken”) appeals from the July 28, 2016 Medical Dispute Opinion and Order rendered by Hon. Jane Rice Williams, Administrative Law Judge (“ALJ”), finding M.H. Logistics (“M.H.”) is not responsible for treatment with Dr. Kyan Htin and prescriptions for Hydrocodone and Gabapentin.  On appeal, Kareken argues the ALJ applied an incorrect burden of proof and failed to state the evidentiary basis for her findings, and that the decision is not supported by substantial evidence.  For the reasons set forth herein, we affirm.

          Kareken was injured on May 3, 2004, when he slipped and fell, resulting in broken hardware from a previous lumbar fusion.  He underwent a repeat lumbar fusion for non-union at L4-5 and replacement of broken hardware on December 6, 2004, and a posterior fusion at L3-S1 with hardware revision on July 5, 2006.  His claim was resolved by settlement agreement approved June 10, 2008.  Kareken received an annuity and medical benefits remained open.

          On December 28, 2015, M.H. filed a Form 112 and motion to reopen to contest the work-relatedness, reasonableness and necessity of treatment with Dr. Htin and prescriptions for Hydrocodone, Gabapentin, Diclofenac and Methocarbamol.  It submitted the October 21, 2015 report of Dr. William Baumgartl, who conducted a medical records review.  He opined Hydrocodone is not medically necessary, as there is no documentation to indicate functional improvement or proper procedures required for prescribing opioid medication.  He further opined Gabapentin is not medically reasonable as there is no indication of neuropathic pain.  Dr. Baumgartl attached to his report a portion of the Official Disability Guidelines (“ODG”), a publication of the Work Loss Data Institute, concerning chronic pain.  The guidelines require ongoing review and documentation of pain relief, functional status, appropriate medication use, and side effects.  The ODG recommends, “consideration of a consultation with a multidisciplinary pain clinic if doses of opioids are required beyond what is usually required for the condition or pain does not improve on opioids in 3 months.”

          M.H. also submitted the report of Dr. Ellen M. Ballard, who performed an independent medical evaluation on March 22, 2016.  Her impressions were history of lumbar surgery with multiple work compensation injuries; history of right shoulder surgery times two and left shoulder surgery with headaches following 2014 motor vehicle accident; and history of three lumbar surgeries with work injuries prior to 2004 injury with likely prior permanent restrictions.  She felt Kareken’s current treatment is reasonable and necessary, but did not feel the current pain treatment is related to the 2004 work injury.  Instead, she related the treatment to multiple pre-existing back problems, a 2014 motor vehicle accident, and shoulder surgeries.  Dr. Ballard indicated Kareken could be weaned from Lortab, but there did not appear to be a good reason for him to stop his other medications. 

          Kareken filed an April 4, 2016 letter from Dr. Stephen Payne stating prescriptions for Robaxin, Diclofenac, and Gabapentin are clearly related to the 2004 injury. 

          Kareken also filed medical records from Dr. Richard T. Holt.  Dr. Holt treated Kareken annually for back, right leg, right groin and testicle pain.  In a February 2, 2011 letter, Dr. Holt stated Kareken has arachnoiditis which is the reason for his continued and probable lifelong need for medications.  On February 1, 2007, Kareken was noted to have a solid fusion, but he continued to have low back pain and his right leg gives out.  Dr. Holt diagnosed low back pain, failed fusion.  In February, 2007, Dr. Holt stated he would cease treating Kareken because the insurance company “is giving me a hard time.” 

          Kareken filed a February 22, 2016 letter from Dr. Htin, who provided pain management treatment.  Dr. Htin noted Kareken had undergone two low back surgeries subsequent to the 2004 work injury.  He has been stable on Norco for pain control.  Dr. Htin opined the medication would be needed for the rest of Kareken’s life and added it would be “inhumane to deny him the basic pain management and medication he requires to live a reasonable life with [sic] undue suffering.” 

          Kareken testified by deposition on March 17, 2016.  Kareken sees Dr. Htin to receive prescriptions for Hydrocodone for the low back condition related to the 2004 injury.  He indicated he had never been prescribed narcotic medications for any other injury.  With the exception of three visits for epidural blocks for his neck, all of his treatment with Dr. Htin has been related to the 2004 injury.  Hydrocodone helps to control his pain but does not completely relieve it.  He continues to have burning, aching and sharp pain in his right leg down to his foot and burning pain in his left leg down to the knee. 

          The ALJ first noted M.H. bore the burden of proof regarding the reasonableness and necessity of the treatment, while Kareken maintained the burden of proving the contested expenses are causally related to the work injury.  The ALJ then determined:

     The numerous health conditions make it very difficult to determine what is and what is not related to the work injury.  That being said, there is no convincing evidence stating why Plaintiff should continue narcotic medications for 12 years after the work injury as these are not recommended for long term control of pain.  Therefore, it is found Hydrocodone and Gabapentin are not work related.  They may be reasonable to treat some other condition but not the work injury.  Absent narcotics, there is no reason why Plaintiff would need to continue treating with Dr. Htin as related to the work injury.  Diclofenac and Robaxin are found reasonable, necessary and work related as stated by the treating physician.  Defendant Employer has met its burden of proving the treatment with Dr. Htin and prescriptions for Hydrocodone and Gabapentin are not reasonable and necessary for the cure, and/or relief of the work injury and non-compensable.  However, Robaxin (methocarbamol) and Diclofenac are found compensable.

 

          On appeal, Kareken argues the ALJ applied an incorrect burden of proof in deciding the dispute, contending the ALJ’s decision implies the burden of proof was on him instead of the party seeking to reopen.  Kareken believes the ALJ’s decision evinces a lack of understanding of the types of medication prescribed, as Gabapentin is not a narcotic.  Kareken argues the ALJ’s finding that narcotic prescriptions are not recommended for long term control of pain is not supported by substantial evidence, and the decision fails to state an evidentiary basis for its conclusions. 

          We begin by noting Kareken did not file a petition for reconsideration and appealed directly to the Board.  An ALJ must be afforded the opportunity to make any corrections, via petition for reconsideration, concerning a misunderstanding of the evidence upon which the fact-finder relies.  Pursuant to KRS 342.285, an award or order of the ALJ shall be conclusive and binding as to all questions of fact if a petition for reconsideration is not filed as provided for in KRS 342.281.  Absent a petition for reconsideration, questions of fact, including the adequacy of the ALJ’s findings of fact, are not preserved for appellate review.  Brasch-Barry General Contractors v. Jones, 175 S.W.3d 81, 83 (Ky. 2005).  See also Hornback v. Hardin Memorial Hospital, 411 S.W.3d 220, 223 (Ky. 2013).  The issue is narrowed to whether the ALJ’s decision is supported by substantial evidence in the record.  Halls Hardwood Floor Co. v. Stapleton, 16 S.W.3d 327 (Ky. App. 2000).  Stated otherwise, inadequate, incomplete, or even inaccurate fact-finding on the part of an ALJ will not justify reversal or remand if there is substantial evidence in the record supporting the ultimate conclusion.  Eaton Axle Corp. v. Nally, 688 S.W.2d 334 (Ky. 1985). 

          Kareken first argues the ALJ improperly placed the burden on him to establish the contested treatments are work-related.  We agree with Kareken that a certain amount of confusion exists in current appellate case law as to which party bears the burden of proving work-relatedness.  See Kingery v. Sumitomo Electric Wiring, 481 S.W.3d 492 (Ky. 2016)(Supreme Court declined to address the issue of which party bears the burden of proof regarding work-relatedness); C&T of Hazard v. Stollings, 2013 WL 5777066 (Ky. 2013)(unpublished opinion placing burden on employer to establish work-relatedness).  A published appellate opinion on this issue would be of benefit to the workers’ compensation bar.  

          However, we need not delve too far into this issue because, here, the ALJ correctly stated M.H. bore the burden of proof regarding the reasonableness and necessity of the contested treatment.  The record contained conflicting evidence regarding the reasonableness and necessity of the prescriptions for Hydrocodone and Gabapentin.  Where evidence is conflicting, the ALJ, as fact-finder, has the discretion to pick and choose whom and what to believe.  Caudill v. Maloney’s Discount Stores, 560 S.W.2d 15 (Ky. 1977). 

          The opinion of Dr. Baumgartl constitutes substantial evidence supporting the ALJ’s determination that prescriptions for Hydrocodone and Gabapentin and the treatment with Dr. Htin are not reasonable and necessary.  Dr. Baumgartl indicated there was not sufficient documentation regarding functional benefit or improvement to support continued treatment with Hydrocodone and Gabapentin.  He noted current guidelines recommend the use of Gabapentin for neuropathic pain, and Kareken’s records do not document the presence of neuropathy. 

          Although no physician directly stated use of narcotics is only proper for short duration treatment of pain, the opinion of Dr. Baumgartl and the incorporated provisions of the ODG provided a reasonable basis for the ALJ to infer long term use of narcotic medication is not recommended.  Dr. Baumgartl’s report establishes long term use of narcotic medication is not acceptable in the absence of proper monitoring and documentation of pain relief, functional status, appropriate medication use, and side effects.  Dr. Baumgartl clearly stated the documentation necessary for continued use was not present in the records.  The ALJ could reasonably conclude continuing use of Hydrocodone and Gabapentin was not reasonable and necessary.  As noted by the ALJ and acknowledged by Kareken, the sole purpose of treatment by Dr. Htin was to obtain narcotic medication that Kareken’s physician could not or would not provide.  Thus, the ALJ could reasonably conclude treatment with Dr. Htin was not reasonable or necessary.  

          Dr. Ballard also opined the current pain treatment was not related to the effects of the 2004 injury.  Instead, she attributed the need for treatment to multiple pre-existing back problems, a subsequent motor vehicle accident, and shoulder surgeries.  There being substantial evidence to support the ALJ’s finding on this issue, it may not be disturbed on appeal.  Special Fund v. Francis, 708 S.W.2d 641 (Ky. 1986).

          Kareken correctly points out the ALJ made a factual finding that Hydrocodone and Gabapentin are not work-related.  However, she also made findings indicating these medications are not reasonable and necessary for the treatment of his work-related injury.  We also acknowledge the ALJ’s erroneous reference to Gabapentin as a “narcotic” pain medication.  Nonetheless, because no petition for reconsideration was filed, we cannot consider the adequacy of the ALJ’s factual findings.  Our review is limited solely to whether the ultimate decision is supported by substantial evidence and, for the reasons set forth above, we conclude that it is.     

          Accordingly, the July 28, 2016 Medical Dispute Opinion and Order rendered by Hon. Jane Rice Williams, Administrative Law Judge, is hereby AFFIRMED.

          ALL CONCUR.

 

 

 

 

 

 

 

 

 

COUNSEL FOR PETITIONER:

 

HON. PETER NAAKE

2303 RIVER RD #300

LOUISVILLE, KY 40206

 

COUNSEL FOR RESPONDENT:

 

HON KYLE L JOHNSON

610 S. 4TH STREET, SUITE 701

LOUISVILLE, KY 40202

 

ADMINISTRATIVE LAW JUDGE:

 

HON JANE RICE WILLIAMS

PREVENTION PARK

657 CHAMBERLIN AVENUE

FRANKFORT, KY 40601